Literature DB >> 8835215

Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin.

P W Cheng1.   

Abstract

A high-efficiency, nonviral gene transfer protocol employing cationic liposome plus a receptor ligand is described. The delivery of the beta-galactosidase (beta-Gal) gene (pCMVlacZ) by lipofectin plus transferrin can achieve 98-100% transfection of HeLa cells as compared to 3-4% by lipofectin alone. A dose-dependent gene transfer was observed between 1 and 16 micrograms transferrin, and maximal transfection efficiency was obtained at > or = 16 micrograms transferrin. The expression of beta-Gal activity in 100% transfected cells decreased progressively with each passage and returned to the baseline value after six passages, indicating that the DNA delivered was only transiently expressed. The amount of DNA delivered to the cells by lipofectin plus transferrin was approximately two times that obtained by lipofectin, which in turn was two times that by transferrin or without lipofectin and transferrin. In addition, DNA can form complexes with lipofectin and transferrin. These results suggest that transferrin enhances gene transfer and expression in the presence of lipofectin by further facilitating the entry of DNA into the cells through the lipofectin-DNA-transferrin complex. The enhancement of liposome-mediated gene transfer efficiency and expression by transferrin varies with different cationic liposomes. The four different liposomes examined show the following relative transfection efficiency: transfectin > lipofectACE > > DC-cholesterol > > lipofectAMINE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835215     DOI: 10.1089/hum.1996.7.3-275

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  15 in total

Review 1.  Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization.

Authors:  R J Mumper; H C Ledebur
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.

Authors:  P G Martini; R Delage-Mourroux; D M Kraichely; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Activation of CMV promoter-controlled glycosyltransferase and beta -galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2'-deoxycytidine.

Authors:  Kyung Hyun Choi; Hesham Basma; Jaswant Singh; Pi-Wan Cheng
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 2.916

Review 4.  Cationic lipid-based gene delivery systems: pharmaceutical perspectives.

Authors:  R I Mahato; A Rolland; E Tomlinson
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

5.  The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.

Authors:  Sang-Soo Kim; Antonina Rait; Farwah Rubab; Abhi K Rao; Michael C Kiritsy; Kathleen F Pirollo; Shangzi Wang; Louis M Weiner; Esther H Chang
Journal:  Mol Ther       Date:  2013-10-11       Impact factor: 11.454

6.  5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.

Authors:  C G Nebigil; J M Launay; P Hickel; C Tournois; L Maroteaux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Enhanced lentiviral vector production in 293FT cells expressing Siglec-9.

Authors:  Toru Shoji; Hiroshi Higuchi; Yoshinori Zaitsu; Ken-Ichi Nishijima; Shinji Iijima
Journal:  Cytotechnology       Date:  2014-01-25       Impact factor: 2.058

8.  Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta.

Authors:  Gerald D Frank; Mizuo Mifune; Tadashi Inagami; Motoi Ohba; Terukatsu Sasaki; Shigeki Higashiyama; Peter J Dempsey; Satoru Eguchi
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

9.  Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo.

Authors:  Kathleen F Pirollo; Antonina Rait; Qi Zhou; Xin-qiao Zhang; Jain Zhou; Chang-Soo Kim; William F Benedict; Esther H Chang
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

10.  Transferrin-associated lipoplexes as gene delivery systems: relevance of mode of preparation and biophysical properties.

Authors:  Nuno Penacho; Ana Filipe; Sérgio Simões; Maria C Pedroso de Lima
Journal:  J Membr Biol       Date:  2008-02-21       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.